
    
      After signed off the informed consent form by patient or surrogate, and after completing the
      screening phase, the patients who fulfill the inclusion and exclusion criteria will be
      randomized 1:1:1:1 to the 4 study arms. All the Patients will receive the study treatment
      drugs for 7 to 14 days. Use Day 28 of last patient as a cut-off day, Collect the follow up
      visit data on both Day 28 and Day 90 of other patientsï¼Ž
    
  